No Picture
News

GenScript Launches Novel Technology Licensed from Amgen for Accelerating Protein and Antibody Purification

AmMag SA magnetic purification system first to offer high throughput of large samples, accelerating early stage drug development

SAN DIEGO, Jan. 14, 2019 /PRNewswire/ — GenScript®, the world’s leading gene synthesis provider, announced today at PepT… […]

No Picture
News

ViaCyte Provides Update on Patent Portfolio in Stem Cell-Derived Cell Replacement Therapies for Type 1 Diabetes and Other Indications

President and CEO Paul Laikind, Ph.D. to give a company update at Biotech Showcase

SAN DIEGO, Jan. 4, 2019 /PRNewswire/ — ViaCyte, Inc., a privately-held regenerative medicine company, today announced 165 new patents were issued in 2018.  These iss… […]

No Picture
News

New Phase 3 Study Findings Show IMBRUVICA® (ibrutinib) Plus Rituximab Significantly Improved Survival Compared to Fludarabine, Cyclophosphamide, and Rituximab (FCR) in Previously Untreated Patients Aged 70 or Younger with Chronic Lymphocytic Leukemia

— First head-to-head trial showing greater safety and efficacy of IMBRUVICA-based therapy versus FCR– Results from this interim analysis featured as a Late-Breaker at ASH 2018 (abstract #LBA-4)

SAN DIEGO, Dec. 4, 2018 /PRNewswire/ — The Janssen Ph… […]